| 2253 |
227: Activation, PPARα |
719: Increase, hepatocellular adenomas and carcinomas |
Dec 31, 2020 |
Dec 31, 2020 |
1 AOP
|
| 340 |
380: Activation, Pre-MIE: Metabolism of AFB1 |
373: Formation, Pro-mutagenic DNA Adducts |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2482 |
239: Activation, Pregnane-X receptor, NR1l2 |
295: Induction, Upregulation of glucuronyltransferase activity |
Sep 14, 2021 |
Sep 14, 2021 |
None
|
| 3100 |
239: Activation, Pregnane-X receptor, NR1l2 |
54: Up Regulation, CD36 |
Nov 30, 2023 |
Mar 27, 2024 |
1 AOP
|
| 3365 |
239: Activation, Pregnane-X receptor, NR1l2 |
2268: Decreased, INSIG1 protein activity |
Oct 22, 2024 |
Feb 10, 2025 |
2 AOPs
|
| 1480 |
1369: Activation, PTGS-1 |
1375: Increase, platelet aggregation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1481 |
1369: Activation, PTGS-1 |
1374: Increase, mucosal blood flow |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1482 |
1369: Activation, PTGS-1 |
1373: Increase, mucous |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1483 |
1369: Activation, PTGS-1 |
1372: Increase, bicarbonate |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1478 |
1370: Activation, PTGS-2 |
1377: Decrease, leukocyte adherence |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1479 |
1370: Activation, PTGS-2 |
1376: Increase, angiogenesis |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 518 |
245: Activation, PXR/SXR |
471: Inhibition, FoxA2 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 526 |
245: Activation, PXR/SXR |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 529 |
245: Activation, PXR/SXR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 284 |
258: Activation, SCD-1 |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1404 |
258: Activation, SCD-1 |
1306: Increased, lipogenesis |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 896 |
480: Activation, SHP |
878: Inhibition, SREBP1c |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1409 |
480: Activation, SHP |
227: Activation, PPARα |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1412 |
480: Activation, SHP |
1307: Inhibition, LXR |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1414 |
480: Activation, SHP |
1308: Inhibition, LRH-1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 987 |
924: Activation, Sp1 |
962: Increase, Mucin production |
Nov 29, 2016 |
Aug 11, 2021 |
None
|
| 482 |
457: Activation, SREBF1 |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 489 |
457: Activation, SREBF1 |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1662 |
457: Activation, SREBF1 |
459: Increased, Liver Steatosis |
Aug 31, 2017 |
Aug 31, 2017 |
1 AOP
|
| 1397 |
1301: Activation, SREBP-1 |
1304: Activation, FXR |
Apr 12, 2017 |
Apr 12, 2017 |
None
|